SCHEMBL32665213

SCHEMBL32665213

CC(=O)N(C)NC[C@H](NC1CCCCO1)C(=O)O

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ITGB1 P05556 1/20 0.32
▸ ITGA4 P13612 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665291 0.88 ITGB1 (0.31) ITGB1ITGA4
SCHEMBL32665115 0.81 SMN1; SMN2 (0.33) ITGB1ITGA4
SCHEMBL32665488 0.72 CPB2 (0.35) ITGB1ITGA4
SCHEMBL30058897 0.72 FOLH1 (0.42) —
SCHEMBL3791895 0.70 SLC6A3 (0.36) —
SCHEMBL30885589 0.70 SLC6A3 (0.36) —
SCHEMBL28786664 0.69 CPB2 (0.46) —
SCHEMBL18396446 0.68 LMNA (0.50) —
SCHEMBL8378099 0.67 ALDH1A1 (0.45) —
SCHEMBL8378101 0.67 ALDH1A1 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022143-A1 Cyclic Peptide Inhibitors of IL-23 JANSSEN PHARMACEUTICA NV (BE) 2026-01-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022143-A1 Cyclic Peptide Inhibitors of IL-23 IL23R, IL17A, IL36G ITGB1 3972/4885ITGA4 4096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback